Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 54 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Bekiari, Eleni  [Clear All Filters]
2018
Bekiari, E., Kitsios K., Thabit H., Tauschmann M., Athanasiadou E., Karagiannis T., et al. (2018).  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. k1310.
Papatheodorou, K., Banach M., Bekiari E., Rizzo M., & Edmonds M. (2018).  Complications of Diabetes 2017.. J Diabetes Res. 2018, 3086167.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA 1c and increased weight loss more than weekly exenatide ER. Annals of Internal Medicine. 168(8), JC46.
Bekiari, E., Karagiannis T., & Tsapas A. (2018).  In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER.. Ann Intern Med. 168(8), JC46.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes, Obesity and Metabolism.
Andreadis, P., Karagiannis T., Malandris K., Avgerinos I., Liakos A., Manolopoulos A., et al. (2018).  Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.. Diabetes Obes Metab. 20(9), 2255-2263.
2019
Stafylidou, M., Paschos P., Katsoula A., Malandris K., Ioakim K., Bekiari E., et al. (2019).  Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.. Clin Gastroenterol Hepatol. 17(9), 1744-1755.e11.
2020
Tsapas, A., Avgerinos I., Karagiannis T., Malandris K., Manolopoulos A., Andreadis P., et al. (2020).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.. Ann Intern Med. 173(4), 278-286.
Mantsiou, C., Karagiannis T., Kakotrichi P., Malandris K., Avgerinos I., Liakos A., et al. (2020).  Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 22(10), 1857-1868.
Liakos, A., Tsapas A., & Bekiari E. (2020).  In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.. Ann Intern Med. 173(12), JC70.
Liakos, A., Tsapas A., & Bekiari E. (2020).  Some glucose-lowering drugs reduce risk for major adverse cardiac events.. Ann Intern Med. 173(2), JC9.
2021
Paschos, P., Ioakim K., Malandris K., Koukoufiki A., Nayfeh T., Akriviadis E., et al. (2021).  Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.. Anaerobe. 71, 102441.
Tsapas, A., Karagiannis T., Avgerinos I., Matthews D. R., & Bekiari E. (2021).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.. Ann Intern Med. 174(1), 141.
Avgerinos, I., Manolopoulos A., Michailidis T., Kitsios K., Liakos A., Karagiannis T., et al. (2021).  Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(3), 822-831.
Tsapas, A., Karagiannis T., Kakotrichi P., Avgerinos I., Mantsiou C., Tousinas G., et al. (2021).  Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(9), 2116-2124.
Karagiannis, T., Tsapas A., Athanasiadou E., Avgerinos I., Liakos A., Matthews D. R., et al. (2021).  GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Res Clin Pract. 174, 108737.
Tsapas, A., Karagiannis T., Avgerinos I., Liakos A., & Bekiari E. (2021).  GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.. Diabetes Res Clin Pract. 177, 108921.
Karagiannis, T., Tsapas A., & Bekiari E. (2021).  KDIGO made 12 recommendations for managing diabetes with CKD.. Ann Intern Med. 174(3), JC26.
Avgerinos, I., Papanastasiou G., Karagiannis T., Michailidis T., Liakos A., Mainou M., et al. (2021).  Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 23(10), 2395-2401.
2022
Karagiannis, T., Avgerinos I., Liakos A., Del Prato S., Matthews D. R., Tsapas A., et al. (2022).  Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.. Diabetologia. 65(8), 1251-1261.
Avgerinos, I., Karagiannis T., Kakotrichi P., Michailidis T., Liakos A., Matthews D. R., et al. (2022).  Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 24(1), 106-114.
2023
Liakos, A., Karagiannis T., Avgerinos I., Tsapas A., & Bekiari E. (2023).  Burden and Coping Strategies of Hypoglycemia in People with Diabetes.. Curr Diabetes Rev.
Malandris, K., Papandreou S., Avgerinos I., Karagiannis T., Paschos P., Michailidis T., et al. (2023).  Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis.. Hormones (Athens). 22(4), 655-664.
Avgerinos, I., Karagiannis T., Matthews D. R., Tsapas A., & Bekiari E. (2023).  Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.. Diabetes Obes Metab. 25(10), 3020-3029.
Liakos, A., Karagiannis T., Avgerinos I., Malandris K., Tsapas A., & Bekiari E. (2023).  Management of type 2 diabetes in the new era.. Hormones (Athens). 22(4), 677-684.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές